Rheumatoid arthritis is a widespread autoimmune disease that is linked to progressive disability, socioeconomic costs, systemic complications, and even early death. In addition to having an unknown cause, the disease also has a guarded prognosis. In the past few years, there have been several attempts to understand the pathogenesis of the disease, which have resulted in the creation of new therapeutics with enhanced outcomes (McInnes & Schett, 2011, p.2205). As a result of this progress, the current treatment strategy for the disease involves initiating aggressive therapy immediately after diagnosis and increasing the therapy. This process is carried out through an evaluation of the disease activity in order to achieve medical remission. While various unmet needs remain, rheumatoid arthritis is characterized by synovial inflammation, systemic attributes, autoantibody production, and cartilage and bone destruction.

Question 2:

Despite being common in the environment, Acinetobacter bacteria are rarely a medical threat to healthy and...
[ View Full Essay]